Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and...
-
Gurugram, Haryana, July 28, 2025 (GLOBE NEWSWIRE) -- Chicken Road is quickly rising to the top in India as one of the most exciting crash-style games in the online gambling world. It is attracting...
-
Novo completed its maiden RC drill program at the Clone prospect as part of the Tibooburra Gold Project in May 2025 testing 500 m of strike. Drilling produced significant high-grade gold intercepts...
-
Austin, TX, USA, July 28, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Badminton Racket Market Size, Trends and Insights By Type (Carbon, Carbon...
-
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 28 July 2025 - Theon International Plc (THEON) (AMS: THEON) is today providing its H1 2025 Trading Update ahead of publishing its H1 2025...
-
OCALA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive data in a mid-year update from the ongoing Phase 2 clinical...
-
Increases total holdings to 1,535,772 HYPE Company to host investor webinar on Tuesday, July 29th at 2:00pm ET LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ:...
-
L’ibrutinib est le premier inhibiteur de la tyrosine kinase de Bruton (BTK) approuvé qui a démontré des résultats statistiquement significatifs par rapport à l’autogreffe de cellules souches (AGCS)...
-
Ibrutinib ist der erste zugelassene Bruton-Tyrosinkinase-Inhibitor (BTKi), der statistisch signifikante Ergebnisse gegenüber der autologen Stammzelltransplantation (ASCT) bei der Erstlinienbehandlung...
-
Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Bi/Multispecific Drug Market with Confidence" report has been added to ResearchAndMarkets.com's offering. The...